STOCK TITAN

[Form 4] Durect Corp Insider Trading Activity

Filing Impact
(Low)
Filing Sentiment
(Neutral)
Form Type
4

Peter S. Garcia, a director of DURECT Corporation (DRRX), received an option grant on 09/09/2025 covering 5,500 shares with an exercise price of $1.22. The Form 4 shows the option is a stock option exercisable for 5,500 shares of common stock and that the reporting person owned 12,500 shares of common stock following the transaction. The disclosure states the option vests 100% on the day before the first anniversary of the grant date, subject to continued service.

Peter S. Garcia, direttore della DURECT Corporation (DRRX), ha ricevuto una concessione di opzioni l'09/09/2025 che copre 5.500 azioni con un prezzo di esercizio di 1,22 $. Il Form 4 mostra che l'opzione è una stock option exercisable per 5.500 azioni ordinarie e che la persona che segnala possedeva 12.500 azioni ordinarie dopo la transazione. La divulgazione indica che l'opzione matura al 100% il giorno precedente al primo anniversario della data di concessione, soggetta al proseguimento del servizio.

Peter S. Garcia, director de DURECT Corporation (DRRX), recibió una concesión de opciones el 09/09/2025 que cubre 5,500 acciones con un precio de ejercicio de 1,22 dólares. El Formulario 4 muestra que la opción es una opción sobre acciones que puede ejercerse por 5.500 acciones ordinarias y que la persona que reporta poseía 12.500 acciones ordinarias tras la transacción. La divulgación indica que la opción se adquiere al 100% el día anterior al primer aniversario de la fecha de concesión, sujeta a la continuación del servicio.

Peter S. Garcia, DRRX의 이사인 Peter S. Garcia는 2025년 9월 9일에 행사 가격 1.22달러로 5,500주를 커버하는 스톡 옵션을 수령했습니다. Form 4에 따르면 이 옵션은 5,500주의 보통주를 행사할 수 있는 스톡 옵션이며, 거래 후 보고자는 12,500주의 보통주를 소유하고 있었습니다. 공시는 이 옵션이 수여일의 첫 기념일 직전의 날에 100%로 취득되며, 지속적 근무 조건에 따라 달성된다고 명시합니다.

Peter S. Garcia, directeur de DURECT Corporation (DRRX), a reçu une attribution d'options le 09/09/2025 couvrant 5 500 actions avec un prix d'exercice de 1,22 $. Le Formulaire 4 indique que l'option est une option d'achat d'actions exerçable sur 5 500 actions ordinaires et que la personne qui déclare détenait 12 500 actions ordinaires après la transaction. La divulgation précise que l'option est acquise à 100 % le jour précédant le premier anniversaire de la date d'attribution, sous réserve de la poursuite du service.

Peter S. Garcia, Direktor der DURECT Corporation (DRRX), erhielt am 09.09.2025 eine Optionszuteilung über 5.500 Aktien zu einem Ausübungspreis von 1,22 $. Das Formular 4 zeigt, dass die Option eine Aktienoption ist, die 5.500 Stammaktien ausübbar macht, und dass die meldende Person nach der Transaktion 12.500 Stammaktien besaß. Die Offenlegung besagt, dass die Option zu 100 % am Tag vor dem ersten Jahrestag des Gewährungsdatums fällig wird, vorbehaltlich der weiteren Dienstzeit.

قد حصل بيتر س. غارسيا، مدير شركة DURECT (DRRX)، على منحة خيار بتاريخ 09/09/2025 تغطي 5,500 سهم بسعر ممارسة 1.22 دولار. يوضح النموذج 4 أن الخيار هو خيار أسهم يمكن ممارسته على 5,500 سهم من الأسهم العادية وأن الشخص المبلّغ يمتلك 12,500 سهم من الأسهم العادية بعد المعاملة. تشير الإفصاح إلى أن الخيار يستحق عند 100% في اليوم السابق لذكرى السنة الأولى لتاريخ المنح، رهناً باستمرار الخدمة.

彼得 S. 加西亚,DURECT 公司(DRRX)的董事,于2025年9月9日获得一项覆盖5,500股、行使价为1.22美元的期权。 Form 4 显示该期权是可对5,500股普通股行使的股票期权,披露人交易完成后持有的普通股为12,500股。披露还表示该期权在授予日的第一周年之前的前一天100%归属,须继续为职务。

Positive
  • Option grant documented: 5,500-share stock option awarded on 09/09/2025
  • Exercise price disclosed: option strike price is $1.22 per share
  • Clear vesting terms: 100% vests one day before the first anniversary, conditioned on continued service
  • Post-transaction ownership disclosed: reporting person beneficially owns 12,500 shares following the grant
Negative
  • None.

Insights

TL;DR: A routine director option grant: modest size, single-year cliff vesting, no other changes reported.

The filing documents a non-derivative stock option award to a director, specifying exercise price, share count, and a one-year cliff vesting schedule. The disclosure is straightforward and follows standard Section 16 reporting requirements. There is no indication in this filing of accelerated vesting, amendments, or dispositions beyond the grant, and no additional corporate actions are disclosed here.

TL;DR: Compensation action recorded: 5,500-share option at $1.22, vesting fully after one year.

The Form 4 details the economic terms: a grant of options exercisable for 5,500 shares at $1.22 and a vesting condition that 100% vests one day before the first anniversary subject to continued service. The report also shows the reporting person beneficially owns 12,500 common shares after the grant. No cash exercises or share sales are reported in this filing.

Peter S. Garcia, direttore della DURECT Corporation (DRRX), ha ricevuto una concessione di opzioni l'09/09/2025 che copre 5.500 azioni con un prezzo di esercizio di 1,22 $. Il Form 4 mostra che l'opzione è una stock option exercisable per 5.500 azioni ordinarie e che la persona che segnala possedeva 12.500 azioni ordinarie dopo la transazione. La divulgazione indica che l'opzione matura al 100% il giorno precedente al primo anniversario della data di concessione, soggetta al proseguimento del servizio.

Peter S. Garcia, director de DURECT Corporation (DRRX), recibió una concesión de opciones el 09/09/2025 que cubre 5,500 acciones con un precio de ejercicio de 1,22 dólares. El Formulario 4 muestra que la opción es una opción sobre acciones que puede ejercerse por 5.500 acciones ordinarias y que la persona que reporta poseía 12.500 acciones ordinarias tras la transacción. La divulgación indica que la opción se adquiere al 100% el día anterior al primer aniversario de la fecha de concesión, sujeta a la continuación del servicio.

Peter S. Garcia, DRRX의 이사인 Peter S. Garcia는 2025년 9월 9일에 행사 가격 1.22달러로 5,500주를 커버하는 스톡 옵션을 수령했습니다. Form 4에 따르면 이 옵션은 5,500주의 보통주를 행사할 수 있는 스톡 옵션이며, 거래 후 보고자는 12,500주의 보통주를 소유하고 있었습니다. 공시는 이 옵션이 수여일의 첫 기념일 직전의 날에 100%로 취득되며, 지속적 근무 조건에 따라 달성된다고 명시합니다.

Peter S. Garcia, directeur de DURECT Corporation (DRRX), a reçu une attribution d'options le 09/09/2025 couvrant 5 500 actions avec un prix d'exercice de 1,22 $. Le Formulaire 4 indique que l'option est une option d'achat d'actions exerçable sur 5 500 actions ordinaires et que la personne qui déclare détenait 12 500 actions ordinaires après la transaction. La divulgation précise que l'option est acquise à 100 % le jour précédant le premier anniversaire de la date d'attribution, sous réserve de la poursuite du service.

Peter S. Garcia, Direktor der DURECT Corporation (DRRX), erhielt am 09.09.2025 eine Optionszuteilung über 5.500 Aktien zu einem Ausübungspreis von 1,22 $. Das Formular 4 zeigt, dass die Option eine Aktienoption ist, die 5.500 Stammaktien ausübbar macht, und dass die meldende Person nach der Transaktion 12.500 Stammaktien besaß. Die Offenlegung besagt, dass die Option zu 100 % am Tag vor dem ersten Jahrestag des Gewährungsdatums fällig wird, vorbehaltlich der weiteren Dienstzeit.

SEC Form 4
FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response: 0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
GARCIA PETER S

(Last) (First) (Middle)
C/O DURECT CORPORATION
10240 BUBB ROAD

(Street)
CUPERTINO CA 95014

(City) (State) (Zip)
2. Issuer Name and Ticker or Trading Symbol
DURECT CORP [ DRRX ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
X Director 10% Owner
Officer (give title below) Other (specify below)
3. Date of Earliest Transaction (Month/Day/Year)
09/09/2025
4. If Amendment, Date of Original Filed (Month/Day/Year)
6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Common Stock 09/09/2025 09/09/2025 M 5,500 A $1.22 12,500 D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Stock Option (right to buy) $1.22 09/09/2025 M 5,500 (1) 09/25/2034 Common Stock 5,500 $0 0 D
Explanation of Responses:
1. 100% of the total number of shares subject to this option grant shall vest and become exercisable on the day before the first anniversary of the date of grant, subject to the Reporting Person continuing to provide services to the Company through the vesting date.
/s/ Peter S. Garcia 09/11/2025
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What transaction did Peter S. Garcia (DRRX) report on Form 4?

He reported a stock option grant of 5,500 options exercisable for common stock, granted on 09/09/2025.

What is the exercise price of the option in the DRRX Form 4?

The exercise price is $1.22 per share as stated in the filing.

When does the 5,500-share option vest according to the filing?

Vesting is 100% one day before the first anniversary of the grant date, subject to continued service.

How many shares did the reporting person own after the reported transaction on DRRX?

12,500 shares of common stock beneficially owned following the reported transaction.

Does the Form 4 report any sales or exercises by Peter S. Garcia?

No sales or exercises are reported; the filing records an option grant and resulting beneficial ownership.
DURECT

NASDAQ:DRRX

DRRX Rankings

DRRX Latest News

DRRX Latest SEC Filings

DRRX Stock Data

59.31M
27.26M
12.67%
23.58%
1.11%
Drug Manufacturers - Specialty & Generic
Pharmaceutical Preparations
Link
United States
CUPERTINO